S195. Improvement in Prolactin and Sexual Side Effects in Patients With Schizophrenia Who Switched From Paliperidone Palmitate or Risperidone Long-Acting Injectable to Aripiprazole Lauroxil

Volume: 85, Issue: 10, Pages: S373 - S373
Published: May 1, 2019
Abstract
Hyperprolactinemia is commonly encountered with risperidone or paliperidone and may lead to sexual dysfunction, amenorrhea, and galactorrhea. We examined changes in prolactin and reported sexual functioning in patients switching from paliperidone palmitate (PP) or risperidone long-acting injectable (RLAI) to aripiprazole lauroxil...
Paper Details
Title
S195. Improvement in Prolactin and Sexual Side Effects in Patients With Schizophrenia Who Switched From Paliperidone Palmitate or Risperidone Long-Acting Injectable to Aripiprazole Lauroxil
Published Date
May 1, 2019
Volume
85
Issue
10
Pages
S373 - S373
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.